Development of type 2 diabetes mellitus in the obese adolescent: A growing challenge

Endocrine Practice

Volumn 18, Issue 5, 2012, Pages 791-795

  Caprio, Sonia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; METFORMIN; ROSIGLITAZONE; TRIACYLGLYCEROL;

BODY MASS; CARDIOVASCULAR DISEASE; CELL FUNCTION; DISEASE COURSE; EDUCATIONAL STATUS; FAMILY HISTORY; FATTY LIVER; FOLLOW UP; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PREVALENCE; PROTEIN SECRETION; REVIEW; SEX DIFFERENCE;

EID: 84867340470     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12142.RA     Document Type: Review

References (24)

1. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and ado-lescents: An epidemiologic review and a public health per-spective. J Pediatr. 2000;136:664-672.
2. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693-700.
3. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, et al. Incidence of dia-betes in youth in the United States (JAMA. 2007;298:627). JAMA. 2007;297:2716-2724.
4. Nadeau KJ, Zeitler PS, Bauer TA, et al. Insulin resis-Tance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab. 2009; 94:3687-3695.
5. TODAY Study Group, Zeitler P, Epstein L, et al. Treat-ment options for type 2 diabetes in adolescents and youth: A study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007; 8:74-87.
6. US Department of Health and Human Services. Healthy People 2012. Washington DC: US Government Printing Office, 2000.
7. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prev-Alence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1782-1732.
8. Copeland KC, Zeitler P, Geffner M, et al TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159-167.
9. Tfyali H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: Insulin sensitivity and secre-Tion in islet cell antibody-negative versus-positive patients. Diabetes. 2009;58:738-744.
10. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glu-cose tolerance and impaired fasting glycaemia: The cur-rent status on definition and intervention. Diabet Med. 2002;19:708-723.
11. Goran MI, Bergman RN, Avila Q, et al. Impaired glu-cose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:207-212.
12. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-A problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004;151:199-206.
13. Brufani C, Ciampalini P, Grossi A, et al. Glucose tol-erance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pedaitr Diabetes. 2010; 11:47-54.
14. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-810.
15. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance and altered myocellular and abdominal fat partitioning. Lancet. 2003;362:951-957.
16. Weiss R, Caprio S, Trombetta M, Taksali SE, Tambo-rlane WV, Bonadonna R. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes. 2005;54:1735-1743.
17. Cali AMG, Bonadonna RC, Trombetta M, Weiss R, Caprio S. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endo-crinol Metab. 2008;93:1767-1773.
18. Cali AM, Man CD, Cobelli C, et al. Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care. 2009;32:456-461.
19. Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese ado-lescent: A determinant of an adverse metabolic syndrome. Diabetes. 2008;57:367-371.
20. Cali AMG, De Oliveira A, Kim H, et al. Glucose dysregu-lation and hepatic steatosis in obese adolescents: Is there a link? Hepatology. 2009;49:1896-1903.
21. Burgert TS, Taksali SE, Dziura J, et al. Alanine amino-Transferase levels and fatty liver in childhood obesity: Asso-ciations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-4294.
22. Nadeau KJ, Klingensmith G, Zeitler P. Type 2 diabe-Tes in children is frequently associated with elevated ala-nine aminotransferase. J Pediatr Gastroenterol Nutr. 2005; 41:94-98.
23. Cali AMG, De Oliveira A, Kim H, et al. Glucose dysregu-lation and hepatic steatosis in obese adolescents: Is there a link? Hepatology. 2009;49:1896-1903.
24. TODAY Study Group, Zeitler P, Hirst K, et al. A clini-cal trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247-2256.